[BXRX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[BXRX] Baudax Bio, Inc.
Announcement Date
08-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -287.80%
YoY- -72.18%
Quarter Report
BXRX's Result
BXRX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 30 -14 310 238 300 422 400 -82.29%
PBT -7,301 -7,386 -9,249 -29,205 -7,531 -12,809 29,434 -
Tax 3,086 206 1,574 509 559 264 -2,893 -
NP -7,375 11,404 -9,249 -29,205 -7,531 -12,809 29,434 -
Tax Rate - - - - - - 9.83% -
Total Cost 7,405 -11,418 9,559 29,443 7,831 13,231 -29,034 -
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -24,583.33 -81,457.14 -2,983.55 -12,271.01 -2,510.33 -3,035.31 7,358.50 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.51 4.91 -5.70 -98.70 -41.95 -79.89 446.40 -
EPS Diluted -1.51 4.91 -5.70 -98.70 -41.95 -79.89 401.20 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.